|
|
Article: Chemo Kine Therapeutics Corp. To Appear on MN1.com.
- Article from:
- M2 Presswire
- Article date:
- September 20, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-20 September 2006-MN1.com: Chemo Kine Therapeutics Corp. To Appear on MN1.com(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:19092006
VANCOUVER, BC - Hassan Salari, CEO, of Chemo Kine Therapeutics Corp. (OTC BB: CHKT), will be featured live on Market News First (www.mn1.com) for an exclusive interview with the MN1 news team. The interview is scheduled for Sept. 26, 2006, at 2:30PM CDT.
(OTC BB: CHKT) Chemokine Therapeutics Corp. is developing drugs that harness the therapeutic potential of stem cells through chemokine pathways. Chemokines are a class of cytokines, proteins which signal biological responses from stem cells that play a ...